초록 ▼

The present invention provides a display assembly including a display screen, a planar light guide, a light source, a light bar, and a frame. The frame is integrally molded with the planar light guide to form a single component, wherein the top and said bottom of the light guide is not obstructed by

The present invention provides a display assembly including a display screen, a planar light guide, a light source, a light bar, and a frame. The frame is integrally molded with the planar light guide to form a single component, wherein the top and said bottom of the light guide is not obstructed by the plastic frame. The planar light guide is disposed above the display screen and provides mechanical support of the display. The light bar is disposed between the planar light guide and the light source, and acts to couple light from the light source into the planar light guide.

대표청구항 ▼

The present invention provides a display assembly including a display screen, a planar light guide, a light source, a light bar, and a frame. The frame is integrally molded with the planar light guide to form a single component, wherein the top and said bottom of the light guide is not obstructed by

The present invention provides a display assembly including a display screen, a planar light guide, a light source, a light bar, and a frame. The frame is integrally molded with the planar light guide to form a single component, wherein the top and said bottom of the light guide is not obstructed by the plastic frame. The planar light guide is disposed above the display screen and provides mechanical support of the display. The light bar is disposed between the planar light guide and the light source, and acts to couple light from the light source into the planar light guide. The method of claim 1, wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G. 4. The method of claim 1, wherein the botulinum toxin is administered in an amount of between 0.01 units and 500 units. 5. The method of claim 1, wherein the botulinum toxin is administered in an amount of between 0.01 unit and 50 units. 6. A method for treating an excessively secreting, cholinergically influenced gland, the method comprising the step of injecting an excessively secreting, cholinergic influenced gland or local gland area of a human patient with a therapeutically effective amount of botulinum toxin type A thereby reducing the excessive glandular secretion, wherein the gland is a sweat gland.